Jarl Hellman
Overview
Explore the profile of Jarl Hellman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
436
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sterner Isaksson S, Imberg H, Hirsch I, Schwarcz E, Hellman J, Wijkman M, et al.
Diabetologia
. 2024 Apr;
67(8):1517-1526.
PMID: 38668761
Aims/hypothesis: Previous studies have shown that individuals with similar mean glucose levels (MG) or percentage of time in range (TIR) may have different HbA values. The aim of this study...
2.
Hellman J, Hartvig N, Kaas A, Moller J, Sorensen M, Jendle J
Diabetes Obes Metab
. 2023 Nov;
26(1):301-310.
PMID: 37926903
Aim: To evaluate whether both bolus insulin injection frequency and smart pen engagement were associated with changes in glycaemic control, using real-world data from adults with type 1 diabetes (T1D)....
3.
Gummesson C, Alm S, Cederborg A, Ekstedt M, Hellman J, Hjelmqvist H, et al.
BMC Med Educ
. 2023 Sep;
23(1):635.
PMID: 37667366
Background: The development of entrustable professional activities (EPAs) as a framework for work-based training and assessment in undergraduate medical education has become popular. EPAs are defined as units of a...
4.
Pylov D, Polonsky W, Imberg H, Holmer H, Hellman J, Wijkman M, et al.
J Diabetes Sci Technol
. 2023 Jul;
19(1):143-152.
PMID: 37501366
Background: The GOLD trial demonstrated that continuous glucose monitoring (CGM) in people with type 1 diabetes (T1D) managed with multiple daily insulin injections (MDI) improved not only glucose control but...
5.
Lind M, Catrina S, Ekberg N, Gerward S, Halasa T, Hellman J, et al.
Diabetes Ther
. 2023 Jul;
14(9):1563-1575.
PMID: 37450196
Introduction: This study utilized continuous glucose monitoring data to analyze the effects of switching to treatment with fast-acting insulin aspart (faster aspart) in adults with type 1 diabetes (T1D) in...
6.
Cederblad L, Eklund G, Vedal A, Hill H, Caballero-Corbalan J, Hellman J, et al.
Diabetes Ther
. 2023 Apr;
14(6):953-965.
PMID: 37052842
Introduction: To improve the utilization of continuous- and flash glucose monitoring (CGM/FGM) data we have tested the hypothesis that a machine learning (ML) model can be trained to identify the...
7.
Nystrom T, Schwarz E, Dahlqvist S, Wijkman M, Ekelund M, Holmer H, et al.
J Diabetes Sci Technol
. 2022 Jun;
18(1):89-98.
PMID: 35677967
Background: People with type 1 diabetes generally view it easier to exercise when having continuous information of the glucose levels. We evaluated whether patients with type 1 diabetes managed with...
8.
Olafsdottir A, Bolinder J, Heise T, Polonsky W, Ekelund M, Wijkman M, et al.
Diabetes Obes Metab
. 2020 Nov;
23(2):619-630.
PMID: 33200487
Aim: To identify responders to continuous glucose monitoring (CGM) in relation to reductions in HbA1c and percentage of time spent in hypoglycaemia after initiation of CGM for individuals with type...
9.
Lind M, Olafsdottir A, Hirsch I, Bolinder J, Dahlqvist S, Pivodic A, et al.
Diabetes Care
. 2020 Nov;
44(1):141-149.
PMID: 33199470
Objective: Continuous glucose monitoring (CGM) reduces HbA and time spent in hypoglycemia in people with type 1 diabetes (T1D) treated with multiple daily insulin injections (MDI) when evaluated over shorter...
10.
Seyed Ahmadi S, Westman K, Pivodic A, Olafsdottir A, Dahlqvist S, Hirsch I, et al.
Diabetes Care
. 2020 Jul;
43(9):2017-2024.
PMID: 32641374
Objective: According to recent guidelines, individuals with type 1 diabetes should spend <4.0% of time per day with glucose levels <3.9 mmol/L (<70 mg/dL) and <1.0% per day with glucose...